Aurinia Renal Assessments 2: Aurinia Renal Response in Lupus With Voclosporin (AURORA2)

The purpose of thisPhase 3 study is assess the long-term safety and tolerability of voclosporin compared with placebo for up to an additional 24 months following completion of treatment in the AURORA 1 study in subjects with lupus nephritis (LN).

To Learn More Contact
Antonia Coeshall at 441962715493 or acoeshall@auriniapharma.com
Laura Lisk at (0)7790555604 or llisk@auriniapharma.com
ClinicalTrials.gov identifier: NCT03597464

Sign up for our Newsletter

Use this tool to search all lupus trials and create a personalized list of studies by the type of lupus you have and where you live.

Sign up